SciELO - Scientific Electronic Library Online

 
vol.30 número4Cisto Nasolabial em idade pediátricaMucormicose Rino-Orbito-Cerebral num doente oncológico pediátrico índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Nascer e Crescer

versão impressa ISSN 0872-0754versão On-line ISSN 2183-9417

Nascer e Crescer vol.30 no.4 Porto dez. 2021  Epub 31-Dez-2021

https://doi.org/10.25753/birthgrowthmj.v30.i4.20110 

Case reports

Infantile hepatic hemangioendothelioma in a newborn

Hemangioendotelioma hepático infantil num recém-nascido

Joana Silva1 
http://orcid.org/0000-0003-3214-6162

Liliana Quaresma1 

Fátima Ribeiro1 

Inês Ferreira1 
http://orcid.org/0000-0002-1877-1511

Eunice Trindade2 

Teresa Caldeira1 

Teresa Andrade1 

1.Neonatology Unit, Department of Pediatric and Neonatology, Centro Hospitalar Entre Douro e Vouga. 4520-211 Santa Maria da Feira, Portugal. nessajoana@gmail.com; lilianaquaresma@hotmail.com; fati.tima@gmail.com; inescasfer@gmail.com; caldeira.teresa@gmail.com; andrade.teresa@gmail.com

2.Pediatric Gastroenterology Unit, Department of Pediatric, Centro Materno Pediátrico, Centro Hospitalar Universitário de São João. 4200-319 Porto, Portugal. eunice_trindade@netcabo.pt


Abstract

Infantile hepatic hemangioendothelioma is the most common benign hepatic vascular tumor in infants younger than six months and may undergo spontaneous regression during the first years of life.

Diagnosis of these lesions in preterm newborns can be challenging, with its timing and accuracy relevant to avoid inappropriate therapeutic measures.

Keywords: hemangioendothelioma; liver tumor; newborn

Resumo

O hemangioendotelioma hepático infantil é o tumor benigno hepático vascular mais comum em lactentes com menos de seis meses, podendo regredir espontaneamente nos primeiros anos de vida.

O diagnóstico destas lesões em recém-nascidos prematuros pode ser um desafio, sendo a sua realização atempada e correta importante para evitar medidas terapêuticas desadequadas.

Palavras-chave: hemangioendotelioma; recém-nascido; tumor hepático

Introduction

Primary liver tumors are rare in the neonatal period, with vascular lesions as the most frequent. (1 Infantile hepatic hemangioendothelioma (IHH) is a benign vascular liver tumor commonly diagnosed within the first six months of life. (2), (3), (4 It is usually asymptomatic and may regress spontaneously within 12 to 18 months. (2), (5 Rarely, it can cause severe symptoms, such as liver dysfunction, congestive cardiac failure, and coagulopathy, requiring aggressive treatment. (2), (6 The diagnosis is established based on the child’s age, clinical features, serum α-fetoprotein level, and imaging findings. (4), (7

Herein the authors report the case of a preterm newborn with hepatic hemangioendothelioma incidentally diagnosed during echocardiographic evaluation in the context of sepsis.

Case report

Herein is reported the case of a male Caucasian newborn, born at 27 weeks of gestational age by spontaneous vaginal delivery after preterm premature rupture of membranes, weighing 1000 g. Physical examination was normal for age.

Eighteen days after admission, the boy developed a clinical-analytical condition compatible with sepsis, being prescribed cefotaxime and vancomycin.

Two intrahepatic cystic lesions were incidentally identified at subcostal view during functional echocardiography. Abdominal ultrasound confirmed the presence of two adjacent cystic hepatic formations in segment VIII, with 13 and 17 mm, both without detectable vascularization (Figure 1). Considering the hypothesis of fungal liver abscesses, amphotericin B was added to antibiotic therapy and maintained for five weeks. In the absence of positive cultures and normal complete blood count, liver function tests, and serum alpha-fetoprotein (AFP) for age (16,692 ng/mL; normal range for age, 134,734 ± 41,444 ng/mL), the hypothesis of hepatic hemangioendothelioma was raised.

Abdominal magnetic resonance imaging (MRI) performed on the 66th day of life confirmed the presence of two hepatic hemangioendotheliomas in segments IV and VIII, with 14 and 12 mm, hypointense on T1- and hyperintense on T2-weighted images (Figure 2).

The boy was discharged home on the 75th postnatal day, clinically asymptomatic. Ultrasound control performed five weeks later showed stable liver lesions. At six-month follow-up, abdominal ultrasonography showed total regression of the previously described masses, and analytical control was normal.

Figure 1 Abdominal ultrasound showing two adjacent cystic formations in segment VIII, with 13 and 17 mm, the largest with some peripheral hyperechogenic areas and the smallest more liquefied, and both without detectable vascularization. 

Figure 2 MRI showing two nodules in segments IV and VIII with 14 and 12 mm, respectively, hypointense on T1- and hyperintense on T2-weighted images, with filling-in in the arteriovenous phase 

Discussion

Functional echocardiography has become an invaluable tool in the Neonatal Intensive Care Unit and was crucial for the incidental diagnosis of the hepatic masses observed in the present case. (8

The differential diagnosis of hepatic masses in neonates can be categorized into congenital, neoplastic, or infectious. In this case, and given the clinical-analytical sepsis condition, the hypothesis of liver abscess was raised. The incidence of liver abscesses in preterm increased over the past two decades, probably due to their increased survival and use of invasive procedures (as umbilical catheterization and central catheters) and total parenteral nutrition. (9 In the present case, the absence of therapeutic response despite escalating therapy required an additional imaging modality to establish the diagnosis. As mass differentiation is complex, only MRI allowed a definitive IHH diagnosis in this case.

Benign liver tumors account for one-third of all hepatic lesions in children. IHH represents the most common benign vascular tumor of the liver, with female predominance and mostly apparent in the first six months of life. (3), (4), (10), (11 It is usually multifocal or diffuse, but single lesions may also be found. (3), (12

In most cases, IHH continues to grow during the first year of life, remaining asymptomatic and only incidentally detected in imaging assessment. During its natural course, spontaneous involution occurs within a few years. (2), (3 In the present patient, total regression occurred within the first year of life, without symptoms.

Despite its benign nature, multiple and diffuse lesions can present with life-threatening complications, including severe hypothyroidism, cardiac failure, fulminant hepatic failure, consumption coagulopathy, or intraabdominal hemorrhage, requiring aggressive treatment. (6), (11

Clinical manifestations ─ as abdominal distension, hepatomegaly, skin hemangioma, anemia, thrombocytopenia (Kasabach-Merritt syndrome), and rarely biliary and gastric outlet obstruction ─ can also occur. (3

The initial diagnostic approach consists of ultrasonography, but contrast-enhanced CT or MRI can provide a more definitive diagnosis. (3 MRI may identify IHH as hypointense on T1- and hyperintense on T2-weighted images and with centripetal or homogeneous enhancement. (13), (14

Some evidence suggests an increased risk of hepatoblastoma in preterm, with early exposure to oxidative stress potentially representing the main etiological factor. Consequently, a high index of suspicion for malignant liver lesions is essential. (15

Serum AFP has been used as an important tumor marker for hepatoblastoma, hepatocellular carcinoma, and germ cell tumors and should be tested in all cases. Although AFP levels may be elevated in IHH, they are never as high as seen in malignant lesions. (2), (4

Symptom severity and tumor size affect treatment decisions, which remain controversial. (6 While asymptomatic lesions may experience spontaneous regression and expectant management can be safely adopted, symptomatic lesions may require aggressive management to avoid severe complications. Several therapeutic options are available, including radiotherapy, hepatic artery ligation, and embolization, but systemic corticosteroids remain the mainstay of treatment. (2), (3

In the present case, nosocomial sepsis led to the diagnosis of hepatic masses, incidentally detected on functional echocardiography and initially interpreted as hepatic abscesses. However, lesion non-regression despite instituted therapy suggested other diagnostic hypotheses.

This case is an example of the diagnostic challenge that hemangioendothelioma represents in the neonatal period, particularly in extremely low birth weight preterm, and of successful conservative management with periodic radiological surveillance.

References

1. von Schweinitz D. Neonatal liver tumours. Semin Neonatol. 2003;8(5):403-10. [ Links ]

2. Maaloul I, Aloulou H, Hentati Y, Kamoun T, Mnif Z, Hachicha M. Infantile hepatic hemangioendothelioma successfully treated by low dose of propranolol. Presse Med. 2017;46(4):454-6. [ Links ]

3. Dasgupta MK, Das S, Patra C, Sarkar S. Symptomatic infantile hepatic hemangioendothelioma successfully treated with steroid. J Clin Neonatol. 2013;2(4):187-9. [ Links ]

4. Chiorean L, Cui XW, Tannapfel A, Franke D, Stenzel M, Kosiak W, et al. Benign liver tumors in pediatric patients - Review with emphasis on imaging features. World J Gastroenterol. 2015;21(28):8541-61. [ Links ]

5. Araujo AR, Maciel I, Costa JC, Vieira A, Enes C, Santos Silva E. Infantile hepatic hemangioendothelioma. A multifocal, bilobular and asymptomatic case with spontaneous regression. Anales de pediatria. 2008;68(5):507-10. [ Links ]

6. Ozdemir ZC, Duzenli Kar Y, Sohret NC, Kebapci M, Bor O. Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma. Drug Discov Ther. 2017;11(3):161-4. [ Links ]

7. Iacobas I, Phung TL, Adams DM, Trenor CC, Blei F, Fishman DS, et al. Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring. The Journal of pediatrics. 2018;203:294-300 e2. [ Links ]

8. Tissot C, Muehlethaler V, Sekarski N. Basics of Functional Echocardiography in Children and Neonates. Front Pediatr. 2017;5:235. [ Links ]

9. Semerci SY, Babayigit A, Cebeci B, Buyukkale G, Cetinkaya M. Hepatic Abscesses in Preterm Infants: Report of Three Cases and Review of the Literature. J Trop Pediatr. 2016;62(3):255-60. [ Links ]

10. Berte N, Filfilan A, Mainard L, Mansuy L, Lemelle JL. Co-existing infantile hepatic hemangioma and mesenchymal hamartoma in a neonate. J Surg Case Rep. 2018;2018(1):rjx260. [ Links ]

11. Shabbir Z, Javaid A, Islah Ud D. Infantile Hepatic Hemangioma. J Pak Med Assoc. 2018;68(12):1846-7. [ Links ]

12. Shamir SB, Kurian J, Kogan-Liberman D, Taragin BH. Hepatic Imaging in Neonates and Young Infants: State of the Art. Radiology. 2017;285(3):763-77. [ Links ]

13. Ehman EC, Torbenson MS, Wells ML, Welch BT, Thompson SM, Garg I, et al. Hepatic tumors of vascular origin: imaging appearances. Abdom Radiol (NY). 2018;43(8):1978-90. [ Links ]

14. Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, et al. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr. 2016;5(3):273-80. [ Links ]

15. Paquette K, Coltin H, Boivin A, Amre D, Nuyt AM, Luu TM. Cancer risk in children and young adults born preterm: A systematic review and meta-analysis. PLoS One. 2019;14(1):e0210366. [ Links ]

Received: May 19, 2020; Accepted: February 12, 2021

Correspondence to Joana Silva Neonatology Unit Department of Pediatric and Neonatology Centro Hospitalar Entre Douro e Vouga 4520-211 Santa Maria da Feira Email: nessajoana@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License